长春高新:9月15日召开董事会会议

Group 1 - The core point of the article is that Changchun High-tech (SZ 000661) announced the convening of its 12th meeting of the 11th Board of Directors on September 15, 2025, to discuss the appointment of a new deputy general manager [1] - For the first half of 2025, the revenue composition of Changchun High-tech is as follows: pharmaceutical industry accounts for 92.83%, real estate for 6.81%, and service industry for 0.36% [1] - As of the time of reporting, the market capitalization of Changchun High-tech is 51.7 billion yuan [1] Group 2 - A significant breakthrough has been reported regarding a new drug from China, which has been recognized by both Chinese and American officials for its breakthrough efficacy, generating excitement at the World Lung Cancer Conference [1]